Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Am J Health Syst Pharm. 2016 Dec 1;73(23):1977–1985. doi: 10.2146/ajhp150977

Figure 1. Initial prioritization considerations for new gene/drug groups.

Figure 1

Used with permission from PharmGKB. PharmGKB® is a registered trademark of the U.S. Department of Health and Human Services and is financially supported by NIH/NIGMS. It is managed at Stanford University.